MétaCan
Menu
← Back to cohort

Global burden of prostate cancer in 38 OECD countries and its trend from 1990-2021: An Insight from the Global Burden of Disease study 2021.

2025· article· en· W4410809147 on OpenAlexaboutno aff
Siddhant Jain, Dhara Popat, Hardik Jain, Mandeepsinh Vashi, Rahil Gadhiya, Fagun Viramgama, Abdullah Jamal, Shivam Kalra, Himanshu Bharatkumar Koyani, Vishrant Amin

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineBurden of diseaseProstate cancerDiseaseDisease burdenCancerGlobal healthEnvironmental healthInternal medicinePublic healthPathology

Abstract

fetched live from OpenAlex

e17005 Background: Prostate cancer (PC) remains a significant public health challenge across Organization for Economic Cooperation and Development (OECD) countries, with its burden steadily increasing due to aging populations, lifestyle changes, and improved diagnostic capabilities. PC ranks as the fifth leading cause of death and the sixth leading cause of disability across the 38 member countries of the OECD. Methods: Using Global Burden of Disease study 2021 methodology, we estimated incidence, prevalence, deaths, disability-adjusted life years (DALYs) due to PC by age, sex, year and location across the 38 OECD countries from 1990-2021. Results: Between 1990 and 2021, the total prevalence count due to PC increased from 2.9 million (95% UI: 2.8–3.0) to 7.1 million (6.7–7.3), while deaths rose from 128,547 (121,475–132,397) to 194,858 (175,334–205,941). The total disability-adjusted life years (DALYs) increased from 2.4 million (2.3–2.5) to 2.9 million (2.8–3.0). The highest annual percentage change (APC) in the age-standardized incidence rate (ASIR) was observed in the Republic of Korea (4.75%), followed by Estonia (4.00%), Latvia (3.30%), Poland (3.01%), Slovenia (2.83%), and Japan (2.50%). In contrast, a decline in ASIR was observed in the USA (-0.41%), Canada (-1.11%), Switzerland (-0.36%), and New Zealand (-0.16%) over the same period. Regarding the age-standardized mortality rate (ASMR), Latvia recorded the highest increase in APC (1.90%), followed by Lithuania (1.62%), Poland (1.48%), the Republic of Korea (1.42%), Slovenia (0.89%), and Costa Rica (0.49%). Age-wise, the highest increase in APC for incidence count was observed in individuals aged 95+ years (5.55%), followed by 90–94 years (4.42%), 50–54 years (3.24%), 85–89 years (3.06%), and 60–64 years (2.80%). In terms of mortality, the highest APC was recorded in the 95+ years group (5.46%), followed by 90–94 years (4.31%), 85–89 years (2.58%), 80–84 years (1.05%), 20–24 years (0.97%), and 70–74 years (0.84%). Conclusions: Deaths due to PC accounted for 6.095% of all cancer causalities in 2021. From 1990 to 2021, the prevalence, mortality, and DALYs of the disease showed a significant rise, with the highest increases in incidence observed in the Republic of Korea, Estonia, and Latvia, while the USA, Canada, and Switzerland saw declines. Mortality rates also surged in Latvia, Lithuania, and Poland, with the elderly population (95+ years) experiencing the steepest rise in both incidence and deaths, highlighting an urgent need for targeted interventions in high-risk regions and age groups.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.118
Threshold uncertainty score0.235

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0040.008
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.285
GPT teacher head0.530
Teacher spread0.245 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicHealth Systems, Economic Evaluations, Quality of Life→French-language works237,207→